OLD Category: immuno-oncology
July 17, 2018 / Cell Reports
HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss Variants
July 16, 2018 / Cancer Discov.
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade
July 14, 2018 / J Invest Dermatol
Multi-Kinase Inhibitor with Anti-p38γ Activity in Cutaneous T-Cell Lymphoma
July 2, 2018 / Cold Spring Harb Perspect Biol
Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer
June 19, 2018 / Oncotarget
Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus
June 13, 2018 / Nature
Induction and transcriptional regulation of the co-inhibitory gene module in T cells
May 30, 2018 / Frontiers in Immunol.
High Densities of Tumor-Associated Plasma Cells Predict Improved Prognosis in Triple Negative Breast Cancer
May 26, 2018 / Clin. Breast Can.
JAK2 and PD-L1 amplification enhance the dynamic expression of PD-L1 in triple negative breast cancer
May 15, 2018 / Clin. Can. Res.